These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27238492)

  • 1. Development of Novel Delivery System for Cardiovascular Drug Molsidomine: Influence of Synthesis Method and Conditions on Molsidomine Release From Its Composites With Hydrophilic Silica In Vitro.
    Dolinina ES; Parfenyuk EV
    J Pharm Sci; 2016 Jun; 105(6):1952-1959. PubMed ID: 27238492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of silica carrier for controlled release of molsidomine: effect of preparation methods of silica matrixes and their composites with molsidomine on the drug release kinetics in vitro.
    Parfenyuk EV; Dolinina ES
    Eur J Pharm Biopharm; 2014 Nov; 88(3):1038-45. PubMed ID: 25269886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Novel Warfarin-Silica Composite for Controlled Drug Release.
    Parfenyuk EV; Dolinina ES
    Pharm Res; 2017 Apr; 34(4):825-835. PubMed ID: 28138879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sol-gel Derived Warfarin - Silica Composites for Controlled Drug Release.
    Dolinina ES; Parfenyuk EV
    Curr Drug Deliv; 2017; 14(5):734-740. PubMed ID: 27774882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of synthesis conditions and release medium pH on release properties of acyclovir - mercaptopropyl modified silica composite.
    Dolinina ES; Akimsheva EY; Parfenyuk EV
    Drug Dev Ind Pharm; 2021 Oct; 47(10):1624-1632. PubMed ID: 35107404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic silica hybrids modified with guanidine containing co-polymers for drug delivery applications.
    Timin AS; Khashirova SY; Rumyantsev EV; Goncharenko AA
    Mater Sci Eng C Mater Biol Appl; 2016 Jul; 64():20-28. PubMed ID: 27127024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of adsorption capacity of mesoporous silica materials for molsidomine: effects of functionalizing and solution pH.
    Alyoshina NA; Agafonov AV; Parfenyuk EV
    Mater Sci Eng C Mater Biol Appl; 2014 Jul; 40():164-71. PubMed ID: 24857479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioactive silica-based drug delivery systems containing doxorubicin hydrochloride: in vitro studies.
    Prokopowicz M; Zegliński J; Gandhi A; Sawicki W; Tofail SA
    Colloids Surf B Biointerfaces; 2012 May; 93():249-59. PubMed ID: 22325320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of magnetic FexOy@silica-pillared clay (SPC) composites via a novel sol-gel route for controlled drug release and targeting.
    Mao H; Liu X; Yang J; Li B; Yao C; Kong Y
    Mater Sci Eng C Mater Biol Appl; 2014 Jul; 40():102-8. PubMed ID: 24857471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of novel delivery system for warfarin based on mesoporous silica: adsorption characteristics of silica materials for the anticoagulant.
    Dolinina ES; Vorobyeva EV; Parfenyuk EV
    Pharm Dev Technol; 2016 Aug; 21(5):546-53. PubMed ID: 26465269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the intracellular release mechanism of hydrophobic cargo and its relation to the biodegradation behavior of mesoporous silica nanocarriers.
    von Haartman E; Lindberg D; Prabhakar N; Rosenholm JM
    Eur J Pharm Sci; 2016 Dec; 95():17-27. PubMed ID: 27267567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sol-gel processing of anti-inflammatory entrapment in silica, release kinetics, and bioactivity.
    Catauro M; Melisi D; Curcio A; Rimoli MG
    J Biomed Mater Res A; 2008 Dec; 87(4):843-9. PubMed ID: 18200553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Novel Oral Formulations of Disulfide Antioxidants Based on Porous Silica for Controlled Release of the Drugs.
    Dolinina ES; Parfenyuk EV
    Materials (Basel); 2021 Feb; 14(4):. PubMed ID: 33670671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and study of organo-modified silica based hydrogels: Rheological properties and drug release kinetics.
    Parfenyuk EV; Dolinina ES; Kraev AS
    J Biomed Mater Res B Appl Biomater; 2024 Jun; 112(6):e35418. PubMed ID: 38786546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of pore size of three-dimensionally ordered macroporous chitosan-silica matrix on solubility, drug release, and oral bioavailability of loaded-nimodipine.
    Gao Y; Xie Y; Sun H; Zhao Q; Zheng X; Wang S; Jiang T
    Drug Dev Ind Pharm; 2016; 42(3):464-72. PubMed ID: 26507935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-arm PEG/silica hydrogel for sustained ocular drug delivery.
    Lu C; Zahedi P; Forman A; Allen C
    J Pharm Sci; 2014 Jan; 103(1):216-26. PubMed ID: 24285503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silica xerogels as pharmaceutical drug carriers.
    Quintanar-Guerrero D; Ganem-Quintanar A; Nava-Arzaluz MG; Piñón-Segundo E
    Expert Opin Drug Deliv; 2009 May; 6(5):485-98. PubMed ID: 19413456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and release behavior of PMMA/silica composite drug delivery system.
    Lin M; Wang H; Meng S; Zhong W; Li Z; Cai R; Chen Z; Zhou X; Du Q
    J Pharm Sci; 2007 Jun; 96(6):1518-26. PubMed ID: 17094137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hollow mesoporous silica as a high drug loading carrier for regulation insoluble drug release.
    Geng H; Zhao Y; Liu J; Cui Y; Wang Y; Zhao Q; Wang S
    Int J Pharm; 2016 Aug; 510(1):184-94. PubMed ID: 27262268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro release of dexmedetomidine from silica xerogel monoliths: effect of sol-gel synthesis parameters.
    Kortesuo P; Ahola M; Kangas M; Yli-Urpo A; Kiesvaara J; Marvola M
    Int J Pharm; 2001 Jun; 221(1-2):107-14. PubMed ID: 11397572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.